Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001562180-21-003138
Filing Date
2021-05-04
Accepted
2021-05-04 16:34:11
Documents
2
Period of Report
2021-04-26

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 3  
1 PRIMARY DOCUMENT primarydocument.xml 3 1715
2 POWER OF ATTORNEY donovan-poa.txt EX-24 2007
  Complete submission text file 0001562180-21-003138.txt   5203
Mailing Address C/O CATABASIS PHARMACEUTICALS, INC. ONE KENDALL SQ. BLDG. 1400E SUITE B14202 CAMBRIDGE MA 02139
Business Address
Donovan Joanne M. (Reporting) CIK: 0001644087 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40236 | Film No.: 21889080

Mailing Address C/O ORBIMED ADVISORS LLC 601 LEXINGTON AVE, 54TH FLR. NEW YORK NY 10022
Business Address C/O ORBIMED ADVISORS LLC 601 LEXINGTON AVE, 54TH FLR. NEW YORK NY 10022 212-739-6451
Edgewise Therapeutics, Inc. (Issuer) CIK: 0001710072 (see all company filings)

EIN.: 821725586 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations